目的 分析S省国谈药“双通道”管理实施现状,并就影响可获得性的因素进行分析,为各地完善相关政策、提高患者用药可获得性提供参考借鉴。方法 数据来源于S省国谈药监测平台,查询官方政策文件和报道分析现状,并采用Excel和世界卫生组织/国际健康行动机构（WHO/HAI）标准调查法进行可获得性分析。结果 S省国谈药“双通道”管理取得初步成效,药品总体可获得性在提高,但不同机构、不同疾病的药品可获得性存在差异,部分品种的可获得性普遍较低。影响可获得性的因素包括政策协同、医疗机构诊疗水平和信息系统建设。结论 建议完善医药机构建设,统筹区域发展;建立沟通协同机制,加强监督管理;构建可及性指标体系,定期开展系统评价,同时加强政策宣传教育。

Objective: The paper analyzes the implementation status of "dual channel" management of national negotiated drugs in S Province, analyzes the factors affecting the availability, so as to provide reference for governments to improve relevant policies, the availability of drugs for patients. Methods: The data were collected from the S Province State-negotiated Drug Monitoring Platform, the official policy documents, reports were investigated, the availability analysis was conducted using Excel, WHO/HAI standard survey method. Results: The "dual channel" management of state-negotiated drugs in S Province achieved initial results, the overall availability of drugs was improving, but there were differences among institutions, diseases, the availability of specific varieties was generally low. The factors affecting accessibility included policy coordination, medical institution diagnosis, treatment level, information system construction. Conclusions: It is suggested to improve the construction of medical institutions, coordinate regional development, establish communication, coordination mechanism, strengthen supervision, management, establish an accessibility index system, carry out systematic evaluation on a regular basis, strengthen policy publicity, education